Ottawa (May 26) - BIOTECanada is pleased to announce the recipients of its annual National Biotechnology Awards. The winners will be honoured at the National Presidents’ Awards Dinner in Toronto on June 19, in conjunction with CANMEDBIO 2006. Rimon Therapeutics is one of two companies selected to win the Promising Early Stage Company Recognition award. Winners in this category are poised to take off and have distinguished themselves from their peers with demonstrated leadership and significant achievement.

For more information see: http://www.biotech.ca/canmedbio/CMB-news-May2606.html